German Parliament Greenlights Sweeping Pharmacy Reforms, Ushering in New Era for Healthcare Access

BERLIN, Germany – The German Bundestag has approved a landmark package of reforms designed to significantly expand the roles and responsibilities of pharmacies across the nation, a move poised to reshape healthcare access for millions. The legislation, known as the Pharmacy Care Enhancement Act (ApoVWG), passed through parliament today, Friday, May 22, 2026, and now moves to the Bundesrat for final ratification, expected as early as June. Championed by Health Minister Nina Warken, the reforms aim to modernize the pharmacy sector, alleviate pressure on general practitioners, and enhance patient care, particularly in underserved rural areas.

The comprehensive bill represents a pivotal shift, granting pharmacists greater autonomy in areas ranging from vaccinations and prescription dispensing to diagnostic testing and preventative health screenings. Proponents argue these changes are long overdue, reflecting the vital role pharmacies played during the COVID-19 pandemic and acknowledging their potential to improve the efficiency and accessibility of the German healthcare system.

Expanding the Pharmacist's Scope: Beyond Dispensing

A central pillar of the new legislation is the dramatic expansion of services pharmacies will be authorized to provide. Building on previous pilot programs for flu and COVID-19 vaccinations, pharmacists will now be permitted to administer a broader spectrum of "inactivated vaccines," including those for tetanus and tick-borne encephalitis (FSME). This provision allows trained pharmacists to vaccinate adults over 18, significantly increasing vaccination points and potentially improving public health outcomes.

Beyond immunizations, pharmacies are set to become more robust centers for early detection and preventative care. Under the approved reforms, they will be able to offer screenings for conditions such as cardiovascular risks, diabetes, and smoking-related issues. Furthermore, rapid tests for various infections, including norovirus and influenza, will be made available, establishing pharmacies as frontline diagnostic hubs. To monitor medication efficacy, standard venous blood draws will also be permitted for patients aged 18 and over, provided the pharmacy staff have the necessary medical training.

Streamlined Prescriptions and Enhanced Medication Access

Perhaps one of the most significant changes for patients involves new rules governing prescription medication. Under strict conditions, pharmacists will be empowered to dispense certain prescription-only medicines without a prior doctor's visit. This includes situations where a patient is on a long-term treatment, allowing for a one-time emergency dispensing of medication already documented in their electronic health record for at least a year. Additionally, pharmacists could directly provide treatment for minor acute illnesses, such as uncomplicated urinary tract infections, thereby reducing the need for an immediate doctor's appointment for common ailments.

The reforms also address longstanding issues of medication availability and bureaucratic hurdles. If a designated discounted medication is out of stock, either in-store or at wholesalers, pharmacists will now be able to immediately supply an equivalent alternative from their inventory. This measure is expected to significantly cut down on patient waiting times and reduce unnecessary trips. Furthermore, the bill introduces restrictions on "zero retaxation," a practice where pharmacies are not reimbursed for dispensed medications due to minor formal errors on prescriptions, aiming to provide greater financial stability for pharmacies.

Operational Flexibility and Financial Stability for Pharmacies

To ensure the long-term sustainability and accessibility of pharmacy services, particularly in rural regions struggling with a declining number of pharmacies and rising operational costs, the legislation introduces several operational adjustments. Pharmacies will gain more flexibility in determining their opening hours, allowing them to adapt schedules to meet local demand more effectively.

The reform package also includes provisions for improved remuneration, with higher compensation planned for night and emergency services. Discussions are ongoing regarding an increase to the fixed dispensing fee, with proposals suggesting an initial rise to EUR 9.00, followed by a subsequent increase to EUR 9.50. These financial incentives are crucial for supporting the nationwide pharmacy network and ensuring reliable local care. Health Minister Warken emphasized that distributing responsibilities across more shoulders, including pharmacists, is key to stabilizing healthcare provision and bolstering the pharmacy sector financially while reducing bureaucratic burdens.

Balancing Perspectives: Criticism and Future Outlook

While broadly welcomed by pharmacy associations and patient advocacy groups who foresee improved access to care and reduced waiting times, the reforms have drawn criticism from some medical associations. Organizations like the National Association of Statutory Health Insurance Physicians (KBV) have voiced concerns regarding patient safety, particularly concerning the independent dispensing of prescription drugs, stressing the need for careful regulation. This ongoing debate highlights the delicate balance between expanding healthcare access and maintaining established oversight mechanisms within the medical community.

The Pharmacy Care Enhancement Act marks a significant modernization effort within the German healthcare system. By empowering pharmacies with a broader range of medical services, Germany aims to create a more resilient, accessible, and responsive healthcare infrastructure. The move recognizes the evolving capabilities of pharmacists and their potential to serve as readily available points of contact for routine medical needs, ultimately contributing to a more efficient and patient-centric healthcare landscape. The final approval from the Bundesrat is keenly awaited, poised to set in motion a transformative period for German pharmacies and the patients they serve.